drugset / Trial / NCT05463497
To Evaluate the Pharmacokinetic Drug Interactions, Safety and Drug Tolerance in Healthy Volunteers
RandomizedSequentialOpen-labelOther
Summary
A randomized, open-label, multiple-dose, 2x3 crossover clinical trial to investigate the pharmacokinetic drug interaction of JW0201 and C2103 or C2104 after oral administration in healthy adults
Timeline
- Start
- 2022-01-17
- Primary completion
- 2022-03-16
- Completion
- 2022-03-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | C2103 | Unknown | — | Oral |
| Subject | C2104 | Unknown | — | Oral |
| Subject | JW0201 | Unknown | — | Oral |
Indications
No indication recorded.